These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
563 related articles for article (PubMed ID: 30159656)
1. The midrange left ventricular ejection fraction (LVEF) is associated with higher all-cause mortality during the 1-year follow-up compared to preserved LVEF among real-world patients with acute heart failure: a single-center propensity score-matched analysis. Borovac JA; Novak K; Bozic J; Glavas D Heart Vessels; 2019 Feb; 34(2):268-278. PubMed ID: 30159656 [TBL] [Abstract][Full Text] [Related]
2. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction. Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602 [TBL] [Abstract][Full Text] [Related]
3. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction. Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180 [TBL] [Abstract][Full Text] [Related]
5. Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction. Brann A; Janvanishstaporn S; Greenberg B JAMA Cardiol; 2020 Sep; 5(9):1027-1035. PubMed ID: 32936274 [TBL] [Abstract][Full Text] [Related]
6. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain). Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J; BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666 [TBL] [Abstract][Full Text] [Related]
8. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction. Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV; Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N; ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002 [TBL] [Abstract][Full Text] [Related]
11. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction. Son MK; Park JJ; Lim NK; Kim WH; Choi DJ Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140 [TBL] [Abstract][Full Text] [Related]
13. Mode of Death Among Japanese Adults With Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction. Kitai T; Miyakoshi C; Morimoto T; Yaku H; Murai R; Kaji S; Furukawa Y; Inuzuka Y; Nagao K; Tamaki Y; Yamamoto E; Ozasa N; Tang WHW; Kato T; Kimura T JAMA Netw Open; 2020 May; 3(5):e204296. PubMed ID: 32379331 [TBL] [Abstract][Full Text] [Related]
14. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction. Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873 [TBL] [Abstract][Full Text] [Related]
15. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes. Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553 [TBL] [Abstract][Full Text] [Related]
16. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study. Vedin O; Lam CSP; Koh AS; Benson L; Teng THK; Tay WT; Braun OÖ; Savarese G; Dahlström U; Lund LH Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28615366 [TBL] [Abstract][Full Text] [Related]
17. Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction. Rovai S; Corrà U; Piepoli M; Vignati C; Salvioni E; Bonomi A; Mattavelli I; Arcari L; Scardovi AB; Perrone Filardi P; Lagioia R; Paolillo S; Magrì D; Limongelli G; Metra M; Senni M; Scrutinio D; Raimondo R; Emdin M; Lombardi C; Cattadori G; Parati G; Re F; Cicoira M; Villani GQ; Minà C; Correale M; Frigerio M; Perna E; Mapelli M; Magini A; Clemenza F; Bussotti M; Battaia E; Guazzi M; Bandera F; Badagliacca R; Di Lenarda A; Pacileo G; Maggioni A; Passino C; Sciomer S; Sinagra G; Agostoni P; Eur J Heart Fail; 2019 Dec; 21(12):1586-1595. PubMed ID: 31782225 [TBL] [Abstract][Full Text] [Related]
18. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry. Yoshikawa Y; Tamaki Y; Morimoto T; Yaku H; Yamamoto E; Inuzuka Y; Ozasa N; Kitai T; Nagao K; Sato Y; Kondo H; Tamura T; Nakagawa Y; Kuwahara K; Kato T; Kimura T PLoS One; 2020; 15(9):e0239100. PubMed ID: 32925953 [TBL] [Abstract][Full Text] [Related]
19. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Rickenbacher P; Kaufmann BA; Maeder MT; Bernheim A; Goetschalckx K; Pfister O; Pfisterer M; Brunner-La Rocca HP; Eur J Heart Fail; 2017 Dec; 19(12):1586-1596. PubMed ID: 28295985 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China. Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]